Catalyst Wire Dossier Catalyst Wire Dossier

CNP520

· Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CNP520, covering 2021-07-08 to 2021-08-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease [Phase 2, Phase 3]

See pricing